Abstract
This cohort study investigates the immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis who had a weak immune response to COVID-19 vaccination.
All Keywords
【초록키워드】 immune response, multiple sclerosis, SARS-CoV-2 vaccine, cohort study, COVID-19 vaccination, Patient, dose, 【제목키워드】 COVID-19, SARS-CoV-2, immunogenicity, Safety, response, Multiple, sclerosis,
【초록키워드】 immune response, multiple sclerosis, SARS-CoV-2 vaccine, cohort study, COVID-19 vaccination, Patient, dose, 【제목키워드】 COVID-19, SARS-CoV-2, immunogenicity, Safety, response, Multiple, sclerosis,
{{{ 추상적인 }}}
이 코호트 연구는 COVID-19 백신 접종에 대한 면역 반응이 약한 다발성 경화증 환자에서 세 번째 SARS-CoV-2 백신 접종의 면역원성과 안전성을 조사합니다.